GlassScriptPhysician profile
Riasat Ali
NPI 1831763465
$5,404.86
in general payments reported to CMS, 2019-2025
16 companies · $1,160 in 2025
The $1,160 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,245 · 2025: $1,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,299 · Food and Beverage: $1,849 · Education: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,298.54 |
| Food and Beverage | $1,849.34 |
| Education | $256.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $2,273.95 | 2024 | Truelok |
| Medline Industries LP | $1,139.17 | 2024 | |
| Arthrex, INC. | $452.20 | 2025 | |
| Supreme Orthopedic Systems, LLC | $353.22 | 2025 | |
| Medical Device Business Services, INC. | $256.98 | 2024 | |
| Arteriocyte Medical Systems, INC. | $242.74 | 2024 | Magellan |
| Kerecis Limited | $164.90 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Bone Support INC. | $145.60 | 2025 | Ceramentbone Void Filler, Cerament G |
| Stryker Corporation | $86.43 | 2025 | Prostep Mica |
| Integra Lifesciences Corporation | $70.46 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Nevro Corp. | $63.93 | 2024 | Senza |
| Abbvie INC. | $53.01 | 2024-2025 | |
| Amgen INC. | $49.53 | 2025 | Krystexxa |
| Paragon 28, INC. | $18.20 | 2024 | Monkey Rings |
| Polaris Technology Solutions LLC | $17.50 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $17.04 | 2025 | Recell, Permeaderm, Cohealyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riasat Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.